Jan Öhrström, a former chief executive of ProFibrix BV, has joined the supervisory board of Netherlands-based Polyganics, a medical technology company. Dr Öhrström began his career as a clinician and held a number of clinical positions at Novo Nordisk A/S before moving into management positions elsewhere. He was instrumental in the 2013 acquisition of ProFibrix by The Medicines Company of the US.
Polyganics announced the appointment on 15 March 2016.
Copyright 2016 Evernow Publishing Ltd